|
|
Prepublished online as a Blood First Edition Paper on April 10, 2003; DOI 10.1182/blood-2003-01-0324.
Previous Article | Table of Contents | Next Article 
Blood, 1 August 2003, Vol. 102, No. 3, pp. 953-955
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Brief report
Factor XIdependence of surface- and tissue factorinitiated thrombus propagation in primates
András Gruber, and
Stephen R. Hanson
From the Department of Biomedical Engineering at Georgia Institute of Technology & Emory University School of Medicine, Atlanta, GA; and the Yerkes National Primate Research Center, Atlanta, GA
Thrombin, generated through activation of factor XI (FXI) and/or tissue factor (TF)factor VIIa, is essential for thrombosis and hemostasis. We investigated the role of FXI-dependent thrombus propagation under arterial flow conditions producing rapid thrombus growth that, after the initiation phase, could limit the availability of TF at the blood/thrombus interface. Thrombosis was initiated by knitted dacron or TF-presenting teflon grafts deployed into arteriovenous shunts in baboons treated with antihuman FXI antibody (aFXI). Although aFXI did not prevent thrombus initiation, it markedly reduced intraluminal thrombus growth on both surfaces. The antithrombotic effect of aFXI was comparable with that of heparin at doses that significantly prolonged the partial thromboplastin time (APTT), prothrombin time (PT), and bleeding time (BT). aFXI also prolonged the APTT, but the PT and BT were unaffected. Thus, antithrombotic targeting of FXI might inhibit thrombosis with relatively modest hemostatic impairment versus strategies targeting other coagulation factors.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. C. White-Adams, M. A. Berny, E. I. Tucker, J. M. Gertz, D. Gailani, R. T. Urbanus, P. G. de Groot, A. Gruber, and O. J.T. McCarty
Identification of Coagulation Factor XI as a Ligand for Platelet Apolipoprotein E Receptor 2 (ApoER2)
Arterioscler Thromb Vasc Biol,
October 1, 2009;
29(10):
1602 - 1607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. I. Tucker, U. M. Marzec, T. C. White, S. Hurst, S. Rugonyi, O. J. T. McCarty, D. Gailani, A. Gruber, and S. R. Hanson
Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI
Blood,
January 22, 2009;
113(4):
936 - 944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Salomon, D. M. Steinberg, N. Koren-Morag, D. Tanne, and U. Seligsohn
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency
Blood,
April 15, 2008;
111(8):
4113 - 4117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Gailani and T. Renne
Intrinsic Pathway of Coagulation and Arterial Thrombosis
Arterioscler Thromb Vasc Biol,
December 1, 2007;
27(12):
2507 - 2513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Tanaka, F. Szlam, H. Y. Sun, T. Taketomi, and J. H. Levy
Thrombin Generation Assay and Viscoelastic Coagulation Monitors Demonstrate Differences in the Mode of Thrombin Inhibition Between Unfractionated Heparin and Bivalirudin
Anesth. Analg.,
October 1, 2007;
105(4):
933 - 939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. J.H. Sachs and B. Nieswandt
In Vivo Thrombus Formation in Murine Models
Circ. Res.,
April 13, 2007;
100(7):
979 - 991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. M. Doggen, F. R. Rosendaal, and J. C. M. Meijers
Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII
Blood,
December 15, 2006;
108(13):
4045 - 4051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Kleinschnitz, G. Stoll, M. Bendszus, K. Schuh, H.-U. Pauer, P. Burfeind, C. Renne, D. Gailani, B. Nieswandt, and T. Renne
Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis
J. Exp. Med.,
March 20, 2006;
203(3):
513 - 518.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Cheng, Y. Zhao, W. E. Lawson, V. V. Polosukhin, J. E. Johnson, T. S. Blackwell, and D. Gailani
The effects of intrinsic pathway protease deficiencies on plasminogen-deficient mice
Blood,
November 1, 2005;
106(9):
3055 - 3057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Jin, P. Pandey, R. E. Babine, J. C. Gorga, K. J. Seidl, E. Gelfand, D. T. Weaver, S. S. Abdel-Meguid, and J. E. Strickler
Crystal Structures of the FXIa Catalytic Domain in Complex with Ecotin Mutants Reveal Substrate-like Interactions
J. Biol. Chem.,
February 11, 2005;
280(6):
4704 - 4712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Day, J. L. Reeve, B. Pedersen, D. M Farris, D. D. Myers, M. Im, T. W. Wakefield, N. Mackman, and W. P. Fay
Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall
Blood,
January 1, 2005;
105(1):
192 - 198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J.H. Wielders, S. Beguin, H. C. Hemker, and T. Lindhout
Factor XI-Dependent Reciprocal Thrombin Generation Consolidates Blood Coagulation when Tissue Factor Is Not Available
Arterioscler Thromb Vasc Biol,
June 1, 2004;
24(6):
1138 - 1142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Shi, G. M. Iverson, J. C. Qi, K. A. Cockerill, M. D. Linnik, P. Konecny, and S. A. Krilis
{beta}2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: Loss of inhibition by clipped {beta}2-glycoprotein I
PNAS,
March 16, 2004;
101(11):
3939 - 3944.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|